ORNITHINE DECARBOXYLASE INHIBITOR
Vaniqa is a prescription drug approved by the Food and Drug Administration (FDA) to reduce unwanted facial hair in women. Vaniqa is also referred to by its drug name, Eflornithine.
Vaniqua is a member of a drug class known as ornithine decarboxylase inhibitors. Vaniqa is believed to work by interfering with hair growth.
How do I take it?
Prescribing information states that Vaniqa is applied topically twice daily.
Vaniqa comes in the form of a cream.
The FDA-approved label for Vaniqa lists common side effects including redness, rash, burning, stinging, or razor bumps.
For more details about this treatment, visit:
Vaniqa – Allergan
We never share your personal information with anyone.